Andrew R. MacRae

Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies

Andrew R. MacRae, Peter A. Kavsak, Viliam Lustig et al. · Clinical Chemistry · 2006 · 202 citations · Full text

Medicine, Cardiology, Internal Medicine +16

Analytic and Clinical Utility of a Next-Generation, Highly Sensitive Cardiac Troponin I Assay for Early Detection of Myocardial Injury

Peter A. Kavsak, Andrew R. MacRae, Marie-Jeanne Yerna et al. · Clinical Chemistry · 2009 · 163 citations · Full text

Medicine, Cardiology, Early Detection +12

Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome

Wendy Y. Craig, James E. Haddow, Glenn E. Palomaki et al. · Prenatal Diagnosis · 2006 · 112 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Short- and Long-Term Risk Stratification Using a Next-Generation, High-Sensitivity Research Cardiac Troponin I (hs-cTnI) Assay in an Emergency Department Chest Pain Population

Peter A. Kavsak, Xuesong Wang, Dennis T. Ko et al. · Clinical Chemistry · 2009 · 89 citations

Medicine, Cardiology, Emergency Medicine +14

The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction

Peter A. Kavsak, Andrew R. MacRae, Viliam Lustig et al. · American Heart Journal · 2006 · 82 citations

Medicine, Cardiology, Internal Medicine +15